#Sweden #Gothenburg #Getinge #Vasoview Hemopro 3 #Endoscopic Vessel Harvesting

Getinge Unveils the Vasoview Hemopro 3 System

Getinge, a leading global medical technology company, announced the launch of its latest innovation, the Vasoview Hemopro 3 Endoscopic Vessel Harvesting (EVH) System. This system includes the Hemopro 3 Harvesting Tool and the corresponding Hemopro 3 Power Supply, specifically designed with clinicians' input and needs in mind. The introduction of this advanced system represents a significant evolution in Getinge's continuing efforts in providing superior support for coronary artery bypass grafting (CABG) procedures.

Background on Endoscopic Vessel Harvesting

Endoscopic vessel harvesting is a minimally invasive procedure widely used to retrieve blood vessels, typically the saphenous vein or radial artery, for CABG surgery. The importance of efficient vessel harvesting cannot be overstated; it plays a crucial role in ensuring procedural success. Poor-quality conduits or incision-related complications can adversely impact patient outcomes and recovery times. When compared to traditional harvesting techniques, EVH is known to offer numerous benefits, including reduced wound complications, less postoperative pain, quicker recovery times, and improved cosmetic results.

Enhancements with the Hemopro 3

Elin Frostehav, President of Acute Care Therapies at Getinge, highlighted the legacy of the Vasoview family, which has set the standard in endoscopic vessel harvesting for nearly three decades. The Hemopro 3 builds upon this legacy with several thoughtful design enhancements based on real-world clinician feedback, further emphasizing Getinge's commitment to innovation in this field.

In the process of launching the Hemopro 3, Getinge has received favorable feedback from early users, demonstrating ongoing refinements in EVH technology. The goal is to maximize conduit quality while ensuring a smoother experience for both patients and clinicians. Close collaboration with specialists in vessel harvesting has helped to advance EVH technology to ensure that it evolves in line with best practice in clinical settings.

Key Features of Vasoview Hemopro 3

The new Vasoview Hemopro 3 incorporates several targeted upgrades to improve ergonomics, energy management, visualization, and workflow efficiency. One significant change is the redesign of the Harvesting Tool, which now features an ergonomic handle reminiscent of a game controller and a soft-touch activation toggle. This design allows for activation with minimal force from various hand positions, enhancing comfort and control during procedures.

Additionally, the Hemopro 3 introduces simplified connectivity through an integrated harvesting tool power cable. This feature facilitates a one-click connection to the newly designed Hemopro 3 Power Supply, thereby eliminating the cumbersome need for extension cable sterilization. The dedicated power supply provides consistent energy delivery, ensuring that cut-and-cautery performance remains efficient with minimal downtime.

Also included are features that enhance visibility, safety, and workflow efficiency during the EVH process. As Cynthia Hougum, Vice President of Cardiovascular Surgery at Getinge, affirms, the Hemopro 3 emphasizes delivering improvements that enhance patient experiences to promote better clinical outcomes safely and reliably.

Launch Availability and Future Plans

The Vasoview Hemopro 3 is currently rolling out in the United States, supported by staff training for local customers. Following this initial launch, plans are in place for phased expansion into international markets, contingent on regulatory approvals and readiness. Notably, the previous model, Vasoview Hemopro 2, will continue to be available alongside the new system until the rollout of Hemopro 3 is fully complete.

For further details regarding the Vasoview Hemopro 3 and Getinge's extensive range of medical solutions, you can visit their official website and product catalog. Getinge's commitment remains steadfast—to ensure optimal care is attainable for every individual and community, enhancing clinical outcomes and streamlining workflows globally.

Conclusion

Getinge's latest innovation not only enhances the vessel harvesting process but signifies a step toward improved patient care in cardiovascular procedures. The advancements introduced with the Vasoview Hemopro 3 could pave the way for more effective surgical outcomes and an overall better experience for both healthcare providers and patients alike.